• Poster

Lapatinib Plus Letrozole Compared With Letrozole Alone as First-Line Therapy in Hormone Receptor Positive HER2+ Metastatic Breast Cancer: A Quality of Life Analysis

Citation

Sherif, B. N., Sherrill, B., Amonkar, M., Wu, Y., Maltzman, J., O'Rourke, L., & Johnston, S. (2009, June). Lapatinib Plus Letrozole Compared With Letrozole Alone as First-Line Therapy in Hormone Receptor Positive HER2+ Metastatic Breast Cancer: A Quality of Life Analysis. Presented at 2009 ASCO Annual Meeting, .

Abstract